TNF and infection: In previous studies, some anti-inflammatory drugs, such as canakinumab (a fully human monoclonal antibody targeting the IL-1β) and methotrexate (a systemic anti- inflammatory drug targeting TNF-α), were limited in clinical practice by frequent infection events (64, 65).